Recio FO - Search Results

1

Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer.

Gwacham NI, Kilowski KA, Recio FO, Awada A, Kuhn TM, Zhu J, Patel A, Ahmad S, McKenzie ND, Kendrick JE, Holloway RW. Gwacham NI, et al. Among authors: recio fo. Gynecol Oncol. 2023 Aug;175:93-96. doi: 10.1016/j.ygyno.2023.06.006. Epub 2023 Jun 15. Gynecol Oncol. 2023. PMID: 37329874

2

A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma.

Piver MS, Recio FO, Baker TR, Hempling RE. Piver MS, et al. Among authors: recio fo. Gynecol Oncol. 1992 Dec;47(3):373-6. doi: 10.1016/0090-8258(92)90142-6. Gynecol Oncol. 1992. PMID: 1473752

3

Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma.

Gal D, Recio FO, Zamurovic D, Tancer ML. Gal D, et al. Among authors: recio fo. Gynecol Oncol. 1991 Aug;42(2):142-5. doi: 10.1016/0090-8258(91)90334-2. Gynecol Oncol. 1991. PMID: 1894173

4

Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study.

Recio FO, Piver MS, Hempling RE. Recio FO, et al. Gynecol Oncol. 1996 Dec;63(3):333-6. doi: 10.1006/gyno.1996.0332. Gynecol Oncol. 1996. PMID: 8946868

5

Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.

Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Blumenson LE. Eltabbakh GH, et al. Among authors: recio fo. Gynecol Oncol. 1998 Nov;71(2):190-5. doi: 10.1006/gyno.1998.5112. Gynecol Oncol. 1998. PMID: 9826459

6

Fused Clitoral Hood Presenting as a Periclitoral Mass.

Maybury EK, Recio FO, Ahmad S, McKenzie ND. Maybury EK, et al. Among authors: recio fo. Obstet Gynecol. 2022 Dec 1;140(6):1056-1060. doi: 10.1097/AOG.0000000000004996. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357995

7

Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation.

McKenzie ND, Ahmad S, Awada A, Kuhn TM, Recio FO, Holloway RW. McKenzie ND, et al. Among authors: recio fo. Life Sci. 2023 Nov 15;333:122178. doi: 10.1016/j.lfs.2023.122178. Epub 2023 Oct 14. Life Sci. 2023. PMID: 37839778 Review.

8

Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.

Recio F, Scalise CB, Loar P, Lumish M, Berman T, Peddada A, Kalashnikova E, Rivero-Hinojosa S, Beisch T, Nicosia B, Farmer T, Dutta P, Malhotra M, ElNaggar AC, Liu MC, Vaccarello L, Holloway RW. Recio F, et al. Gynecol Oncol. 2024 Mar;182:63-69. doi: 10.1016/j.ygyno.2023.12.025. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262240 Free article.

9

Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.

Goldberg JM, Piver MS, Hempling RE, Recio FO. Goldberg JM, et al. Among authors: recio fo. Gynecol Oncol. 1996 Dec;63(3):312-7. doi: 10.1006/gyno.1996.0328. Gynecol Oncol. 1996. PMID: 8946864

10

Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.

Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Aiduk C. Eltabbakh GH, et al. Among authors: recio fo. Gynecol Oncol. 1997 Jul;66(1):103-7. doi: 10.1006/gyno.1997.4723. Gynecol Oncol. 1997. PMID: 9234929 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page